atosiban pharmidea 37,5 mg/5 ml konzentrat zur herstellung einer infusionslösung
pharmidea sia - atosiban acetat -
atosiban pharmidea 6,75 mg/0,9 ml injektionslösung
pharmidea sia - atosiban acetat -
cancidas (previously caspofungin msd)
merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimykotika zur systemischen anwendung - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.
ethylenglycol-dimethacrylat (egdma) 2%
smartpractice europe gmbh (8106407) - ethylendimethacrylat - salbe - teil 1 - salbe; ethylendimethacrylat (14493) 16,96 milligramm
naphthol as 1%, testsalbe
smartpractice europe gmbh (8106407) - 3-hydroxy-n-phenylnaphthalin-2-carboxamid - salbe - teil 1 - salbe; 3-hydroxy-n-phenylnaphthalin-2-carboxamid (37569) 8,48 milligramm
norepinephrin kalceks 1 mg/ml konzentrat zur herstellung einer infusionslösung
as "kalceks" beiname: jsc "kalceks" (8174981) - norepinephrintartrat/noradrenalintartrat - konzentrat zur herstellung einer infusionslösung - 1 mg/ml - teil 1 - konzentrat zur herstellung einer infusionslösung; norepinephrintartrat/noradrenalintartrat (00230) 2 milligramm
bupivacain grindeks spinal 5 mg/ml injektionslösung
as grindeks - bupivacainhydrochlorid monohydrat -
bupivacain grindeks 5 mg/ml injektionslösung
as grindeks - bupivacainhydrochlorid monohydrat -
oxytocin grindeks 5 i.e./ml injektions-/infusionslösung
as grindeks - oxytocin -
droperidol kalceks 1,25 mg/ml injektionslösung
as kalceks - droperidol -